Alpine Global Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-162,912
| Closed | -$144K | – | 556 |
|
|
2022
Q4 | $144K | Buy |
+162,912
| New | +$144K | 0.05% | 116 |
|
|
2022
Q1 | – | Sell |
-25,893
| Closed | -$120K | – | 815 |
|
|
2021
Q4 | $120K | Buy |
+25,893
| New | +$120K | 0.02% | 622 |
|
|
2020
Q4 | – | Sell |
-30,200
| Closed | -$337K | – | 329 |
|
|
2020
Q3 | $337K | Buy |
+30,200
| New | +$337K | 0.07% | 127 |
|
|
2020
Q1 | – | Sell |
-18,631
| Closed | -$63K | – | 491 |
|
|
2019
Q4 | $63K | Buy |
+18,631
| New | +$63K | 0.01% | 383 |
|
|
2019
Q1 | – | Sell |
-148,195
| Closed | -$356K | – | 227 |
|
|
2018
Q4 | $356K | Buy |
+148,195
| New | +$356K | 0.09% | 109 |
|
|
2018
Q2 | – | Sell |
-19,018
| Closed | -$98K | – | 127 |
|
|
2018
Q1 | $98K | Sell |
19,018
-18,864
| -50% | -$97.2K | 0.02% | 96 |
|
|
2017
Q4 | $144K | Buy |
+37,882
| New | +$144K | 0.03% | 142 |
|